Nivolumab,Ipilimumab
BMS
[]
nivolumab plus ipilimumab or chemo maintains os benefit in escc in long-term results #gi23 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.